Arix Bioscience PLC:企業のM&A・事業提携・投資動向

◆英語タイトル:Arix Bioscience PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1492
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:68
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Arix Bioscience PLC – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Arix Bioscience PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Arix Bioscience PLC since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Arix Bioscience PLC’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Arix Bioscience PLC. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Arix Bioscience PLC’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Arix Bioscience PLC and its subsidiaries since 2007.
- Information about key financial and legal advisors for Arix Bioscience PLC’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Arix Bioscience PLC’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
CORPORATE VENTURING 8
Corporate Venturing – Overview 8
Corporate Venturing – Deal reports 9
PARTNERSHIP 31
Partnership – Overview 31
Partnership – Deal reports 32
CAPITAL RAISING 45
Capital Raising – Overview 45
Capital Raising – Deal reports 46
APPENDIX 58
Contact Us 58
About MarketLine Financial Deals Database 58
Deal Definition and Methodology 60
About MarketLine 67

List of Tables
Table 1: Arix Bioscience PLC corporate venturing volume and value trend (2014-YTD2018)
Table 2: Arix Bioscience PLC corporate venturing by geography (2014-YTD2018)
Table 3: Arix Bioscience PLC partnership volume and value trend (2014-YTD2018)
Table 4: Arix Bioscience PLC partnership trend by key deal type (2014-YTD2018)
Table 5: Arix Bioscience PLC capital raising volume and value trend (2014-YTD2018)
Table 6: Arix Bioscience PLC capital raising by deal type (2014-YTD2018)

List of Figures
Figure 1: Arix Bioscience PLC corporate venturing volume and value trend (2014-YTD2018)
Figure 2: Arix Bioscience PLC corporate venturing by geography (2014-YTD2018)
Figure 3: Arix Bioscience PLC partnership volume and value trend (2014-YTD2018)
Figure 4: Arix Bioscience PLC partnership trend by key deal type (2014-YTD2018)
Figure 5: Arix Bioscience PLC capital raising volume and value trend (2014-YTD2018)
Figure 6: Arix Bioscience PLC capital raising by deal type (2014-YTD2018)

★海外企業調査レポート[Arix Bioscience PLC:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Findel plc:企業の戦略・SWOT・財務分析
    Findel plc - Strategy, SWOT and Corporate Finance Report Summary Findel plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Perrigo Co Plc (PRGO):企業の財務・戦略的SWOT分析
    Perrigo Co Plc (PRGO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • NextEra Energy Resources LLC:電力:M&Aディール及び事業提携情報
    Summary NextEra Energy Resources, LLC (NEER), a subsidiary of NextEra Energy, Inc., is a diversified clean energy company and is one of the largest wholesale generators of electric power in the US. The company, together with its subsidiaries owns, develops, constructs, manages and operates electrici …
  • ValiRx Plc (VAL)-医療機器分野:企業M&A・提携分析
    Summary ValiRx Plc (ValiRx) is a biopharmaceutical company that develops technologies and therapeutic options for the treatment of cancer. The company’s products and technology include GeneICE-silencing rebellious genes, GeneICE – BCL-2, VAL201-prostate cancer, NAV3 cancer screening test and VAL401- …
  • St. Augustine Gold and Copper Limited:企業の戦略・SWOT・財務情報
    St. Augustine Gold and Copper Limited - Strategy, SWOT and Corporate Finance Report Summary St. Augustine Gold and Copper Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Renewable Energy Group, Inc.:企業の戦略・SWOT・財務分析
    Renewable Energy Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Renewable Energy Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • National Jewish Health-製薬・医療分野:企業M&A・提携分析
    Summary National Jewish Health (NJH), formerly National Jewish Medical and Research Center is a healthcare center that offers treatment of pulmonary, cardiac, immune and related disorders. The center offers services in the areas of allergy, asthma, cardiology, clinical immunology, COPD, environmenta …
  • Hummingbird Diagnostics GmbH:企業の製品パイプライン分析
    Summary Hummingbird Diagnostics GmbH (Hummingbird), is a provider of clinical research and testing services. It develops miRNA-based liquid biopsy diagnostics that find application in early detection of disease indications. The company discovers, validates and analyzes genomic biomarkers especially …
  • Typhoon Exploration Inc (TYP):企業の財務・戦略的SWOT分析
    Summary Typhoon Exploration Inc (Typhoon Exploration) is a mineral exploration company. The company carries out acquisition, exploration and development of gold assets. It provides technology for exploration projects. Typhoon Exploration’s operational areas include Monexco, Fayolle, Faille 1, Destor …
  • Mirabilis Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Mirabilis Medical Inc (Mirabilis Medical) is a healthcare equipment company that develops a non-invasive therapeutic ultrasound platform for the treatment of uterine fibroids in women. The company offers platform that targets symptoms of uterine fibroids such as pain, abnormal bleeding, preg …
  • Wesfarmers Ltd (WES)-エネルギー分野:企業M&A・提携分析
    Summary Wesfarmers Limited (Wesfarmers) is a diversified company that has business operations in retail and industrial activities. Its retail activities include supermarkets, liquor, hotels and convenience stores; department stores; home improvement and office supplies; and apparel retailing. The co …
  • Citius Pharmaceuticals Inc (CTXR)-製薬・医療分野:企業M&A・提携分析
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc, is a specialty pharmaceutical company that focused on the development and commercialization of adjunctive cancer care and critical care drug products. The company‘s proprietary product candidates include mino-lok, an antibiotic loc …
  • Meera Industries Ltd (540519):企業の財務・戦略的SWOT分析
    Meera Industries Ltd (540519) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Cipla Limited:企業の戦略・SWOT・財務分析
    Cipla Limited - Strategy, SWOT and Corporate Finance Report Summary Cipla Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Airbus SAS:企業のM&A・事業提携・投資動向
    Airbus SAS - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Airbus SAS Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • HORNBACH-Baumarkt-AG (HBM):企業の財務・戦略的SWOT分析
    HORNBACH-Baumarkt-AG (HBM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Petroleos de Venezuela SA-石油・ガス分野:企業M&A・提携分析
    Summary Petroleos de Venezuela SA (PDVSA) is a state-owned oil and gas company. It plans, coordinates, supervises, and controls the activities in the entire oil and gas value chain. The company explores for and develops oil and other hydrocarbons; refines, trades, and supplies that in domestic and o …
  • Massy United Insurance Ltd:企業の戦略的SWOT分析
    Massy United Insurance Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • GWA Group Limited (GWA):企業の財務・戦略的SWOT分析
    GWA Group Limited (GWA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Zeltiq Aesthetics Inc (ZLTQ)-医療機器分野:企業M&A・提携分析
    Summary Zeltiq Aesthetics Inc (Zeltiq), a subsidiary of Allergan Plc is a medical technology company that develops and commercializes products of cooling technology. The company offers CoolSculpting System utilizing proprietary controlled-cooling technology to selectively reduce stubborn fat bulges. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆